- Home
- AUBN vs NRXS Comparison
AUBN vs NRXS Comparison
Compare AUBN & NRXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | AUBN | NRXS |
|---|---|---|
| Founded | 1907 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 88.8M | 78.9M |
| IPO Year | 1996 | 2023 |
Fundamental Metrics
Financial Performance| Metric | AUBN | NRXS |
|---|---|---|
| Price | $26.55 | $6.07 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $13.00 |
| AVG Volume (30 Days) | 497.0 | ★ 80.0K |
| Earning Date | 04-28-2026 | 05-12-2026 |
| Dividend Yield | ★ 4.61% | N/A |
| EPS Growth | 13.66 | ★ 22.13 |
| EPS | ★ 1.29 | N/A |
| Revenue | $619,000.00 | ★ $3,569,282.00 |
| Revenue This Year | N/A | $172.91 |
| Revenue Next Year | N/A | $115.71 |
| P/E Ratio | $20.54 | ★ N/A |
| Revenue Growth | 0.81 | ★ 32.89 |
| 52 Week Low | $21.60 | $2.21 |
| 52 Week High | $28.88 | $9.33 |
Technical Indicators
Market Signals| Indicator | AUBN | NRXS |
|---|---|---|
| Relative Strength Index (RSI) | 52.43 | 42.39 |
| Support Level | $25.13 | $6.04 |
| Resistance Level | $26.58 | $7.37 |
| Average True Range (ATR) | 0.17 | 0.24 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 47.50 | 43.89 |
Price Performance
Historical ComparisonAbout AUBN Auburn National Bancorporation Inc.
Auburn National Bancorp Inc is a bank holding company registered with the Board of Governors of the Federal Reserve System (the Federal Reserve). As a bank holding company, the Company may diversify into a broader range of financial services and other business activities than are currently permitted to the Bank under applicable laws and regulations. The holding company structure also provides greater financial and operating flexibility than is presently permitted to the Bank. The Company's business is conducted through the Bank and its subsidiaries. Although it has no immediate plansto conduct any other business, the Company may engage directly or indirectly in several activities closely related to banking permitted by the Federal Reserve.
About NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).